Patients at the Point of Care
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
Testing Trends-dtet
Choosing and Using Wisely
The value of lab test utilization management—and the ASCP’s 2024 best practice recommendations for effective test utilization
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
CDC Calls Continued Rise in Cases of STIs “Alarming”
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
How Could Cheaper Genomic Sequencing Affect the Clinical Testing Industry?
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
Expert Q&A: Recent Trends in the Clinical Lab
G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.
USPSTF Again Declines to Recommend Lipid Screening for Asymptomatic Children
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.
Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
Huge Decline in Medicare Laboratory Testing Due to COVID-19
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
How the Use of MALDI-TOF MS Is Expanding in Clinical Diagnostics
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
New Study Supports Accuracy of Diagnoses from Video Visits
Video telehealth during the early period of the COVID-19 quarantine was actually highly effective in providing accurate diagnoses, research shows.
Blood-Based Alzheimer’s Tests Are Here, but Not Ready for Widespread Use
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.
Telehealth Doesn’t Discourage In-Person Care or Drive Wasteful Use
Two recent studies show that most people see telehealth as a supplement to in-person visits, rather than a replacement.
